Literatur
Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (2015) Krebs in Deutschland 2011/2012, 10. Aufl. Robert Koch-Institut, Berlin
Nussbaum N, George DJ, Abernethy AP et al (2016) Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science. Prostate Cancer Prostatic Dis 19:111–121
Schmuck S, von Klot CA, Henkenberens C et al (2017) Initial experience with volumetric 68Ga-PSMA I&T PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with prostate cancer. J Nucl Med 58:1962–1968
Schmuck S, Nordlohne S, von Klot CA et al (2017) Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer. Eur J Nucl Med Mol Imaging 44:960–968
Young JD, Abbate V, Imberti C et al (2017) 68Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room-temperature, 1‑step kit-based radiolabeling. J Nucl Med 58:1270–1277
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Derlin bekam Reisekostenunterstützung von der ROTOP Pharmaka GmbH.
Rights and permissions
About this article
Cite this article
Derlin, T. Kit-basierte Markierung von PSMA-Liganden. Radiologe 58, 189–191 (2018). https://doi.org/10.1007/s00117-018-0362-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-018-0362-z